Product Information
FLUVOXAMINE ER 150 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $4.9611 per EA under NDC 00228284903. Its NADAC has been published 611 times since Oct 15, 2014.
Strength
150 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228284903
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FLUVOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA091482On Market Since
8/5/2014
Pharmacological Classes
Price Statistics
The NADAC for FLUVOXAMINE ER 150 MG CAPSULE has been published 611 times since Oct 15, 2014, and over the history we have for it it has declined 35.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.9611 per EA |
|---|---|
| All-time high | $7.9662 (Mar 11, 2015) |
| All-time low | $3.6682 (Jul 17, 2024) |
| 52-week high | $5.6209 |
| 52-week low | $4.7857 |
| Median price | $6.6861 |
| Average price | $6.4886 |
| Largest weekly change | -33.5% (Apr 17, 2024) |
| Weeks tracked | 611 |
| Tracking since | Oct 15, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FLUVOXAMINE ER 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE ER 150 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $4.9611 per EA (NDC 00228284903), effective Jun 24, 2026.
How has the price of FLUVOXAMINE ER 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has declined 35.9%. It has been tracked across 611 weekly CMS publications since Oct 15, 2014.
What are the highest and lowest recorded NADAC prices for FLUVOXAMINE ER 150 MG CAPSULE?
Since Oct 15, 2014, the NADAC for FLUVOXAMINE ER 150 MG CAPSULE has ranged from a low of $3.6682 (Jul 17, 2024) to a high of $7.9662 (Mar 11, 2015), with a median of $6.6861 per EA.
Are there cheaper alternatives to FLUVOXAMINE ER 150 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as FLUVOXAMINE ER 150 MG CAPSULE, but none are currently priced below it.
Who manufactures FLUVOXAMINE ER 150 MG CAPSULE?
FLUVOXAMINE ER 150 MG CAPSULE (NDC 00228284903) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification